Control of Chemicals Ordinance (Amendment of Schedule 2) Order 2022

Notifying member
Hong Kong, China
Title
Control of Chemicals Ordinance (Amendment of Schedule 2) Order 2022
First published
20/10/2022
First EIF
16/12/2022
Latest published
In force to
Latest notification
G/LIC/N/3/HKG/27
Product categories
List of products subject to licensing
Nature of licensing
Administrative purpose/measure being implemented
Administrative body(ies) for submission of applications
Contact point for information on eligibility

Same as the "Administrative bodies"

Expected duration of licensing procedure
Found by secretariat
No
Related document symbols
  • G/LIC/N/2/HKG/22
Source
Notes
  • G/LIC/N/2/HKG/22

    From 16 December 2022, three substances (i.e., 4-anilinopiperidine, tert-butyl 4-(phenylamino)piperidine-1-carboxylate, and norfentanyl) added to the control under the Control of Chemicals Ordinance.


    The amendments aimed to deter the trafficking and abuse of these dangerous drugs and substances and

    help fortify Hong Kong's defence in the fight against drugs.


    Modification of specific details in existing procedures: Product coverage

    From 16 December 2022, nine substances (i.e., brorphine, clonazolam, CUMYL-PEGACLONE, diclazepam, diphenidine, flubromazolam, isotonitazene, MDMB-4en-PINACA, and metonitazene) have been put under the same strict control as other dangerous drugs under the Dangerous Drugs Ordinance ("DDO"); and three substances (i.e., 4-anilinopiperidine, tert-butyl 4-(phenylamino)piperidine-1-carboxylate, and norfentanyl) added to the control under the Control of Chemicals Ordinance. Also, from 1 February 2023, CBD has been put under the same strict control as other dangerous drugs under the DDO. Hong Kong Harmonized System (HKHS) codes of the concerned substances are tabulated in the Annex of this notification. The amendments aimed to deter the trafficking and abuse of these dangerous drugs and substances and help fortify Hong Kong's defence in the fight against drugs.